Author:
Chuang Cynthia,Busse Paul,Palmer Matthew,Thomas Peter,Zamenhof Robert
Reference6 articles.
1. K. Hanazaki, N. Kawamura, H. Sodeyama, M. Wakabayashi, S. Yokoyama, Y. Sode, T. Miyazaki, and Y. Okazaki, Carcinoembryonic antigen and intra-arterial chemotherapy response of liver metastases, Hepatogastroenterology, 45(20):462–467, 1998.
2. M. O’Connell, D. Nagorney, A. Bernath, and G. Schroeder, Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver, J. Clin. Oncol., 16(7):2528–2533, 1998.
3. B. Hill, T. Minard, and L. Brady, Mococlonal antibodies in the treatment of metastatic carcinoma to the liver: undated report of a pilot study including leukapheresis, Am. J. Clin. Oncol., 21(3):291–293, 1998.
4. J. Seitz, P. Rougier, and M. Giovannini, Recent Advances in systemic chemotherapy of metastatic col-orectal cancer, Ann. Ital. Chir., 67(6):805–812, 1996.
5. T. Pinelli, S. Altieri, F. Fossati, and A. Zonta, Development of a method to use boron neutron capture therapy for diffused tumours of liver (Taormina Project), in: “Cancer Neutron Capture Therapy,” Y. Mishima ed., Plenum Press, New York, 1996, pp. 783–794.